BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19415718)

  • 21. The Dynamics of Transcriptional Activation by Hepatic Reprogramming Factors.
    Horisawa K; Udono M; Ueno K; Ohkawa Y; Nagasaki M; Sekiya S; Suzuki A
    Mol Cell; 2020 Aug; 79(4):660-676.e8. PubMed ID: 32755593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel mechanism of transcriptional repression of the human ATP binding cassette transporter A1 gene in hepatic cells by the winged helix/forkhead box transcription factor A2.
    Thymiakou E; Kardassis D
    Biochim Biophys Acta; 2014 Jun; 1839(6):526-36. PubMed ID: 24807696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of the liver enriched protein FOXA2 recovers HNF6 activity in human colon carcinoma and liver hepatoma cells.
    Lehner F; Kulik U; Klempnauer J; Borlak J
    PLoS One; 2010 Oct; 5(10):e13344. PubMed ID: 20967225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors.
    Sekiya S; Suzuki A
    Nature; 2011 Jun; 475(7356):390-3. PubMed ID: 21716291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Foxa3 (HNF-3gamma) binds to and activates the rat proglucagon gene promoter but is not essential for proglucagon gene expression.
    Liu Y; Shen W; Brubaker PL; Kaestner KH; Drucker DJ
    Biochem J; 2002 Sep; 366(Pt 2):633-41. PubMed ID: 12000309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pioneer transcription factors Foxa1 and Foxa2 regulate alternative RNA splicing during thymocyte positive selection.
    Lau CI; Rowell J; Yanez DC; Solanki A; Ross S; Ono M; Crompton T
    Development; 2021 Aug; 148(15):. PubMed ID: 34323272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.
    Song Y; Washington MK; Crawford HC
    Cancer Res; 2010 Mar; 70(5):2115-25. PubMed ID: 20160041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.
    Li Z; Tuteja G; Schug J; Kaestner KH
    Cell; 2012 Jan; 148(1-2):72-83. PubMed ID: 22265403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foxa1 and Foxa2 regulate bile duct development in mice.
    Li Z; White P; Tuteja G; Rubins N; Sackett S; Kaestner KH
    J Clin Invest; 2009 Jun; 119(6):1537-45. PubMed ID: 19436110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative genomic analysis identifies that SERPINA6-rs1998056 regulated by FOXA/ERα is associated with female hepatocellular carcinoma.
    Shen N; Gong J; Wang Y; Tian J; Qian J; Zou L; Chen W; Zhu B; Lu X; Zhong R; Guo A; Wang L; Miao X
    PLoS One; 2014; 9(9):e107246. PubMed ID: 25198130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic FOXA3 overexpression prevents Western diet-induced obesity and MASH through TGR5.
    Gopoju R; Wang J; Pan X; Hu S; Lin L; Clark A; Xu Y; Yin L; Wang X; Zhang Y
    J Lipid Res; 2024 Apr; 65(4):100527. PubMed ID: 38447926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver.
    Moya M; Benet M; Guzmán C; Tolosa L; García-Monzón C; Pareja E; Castell JV; Jover R
    PLoS One; 2012; 7(1):e30014. PubMed ID: 22238690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conversion of hepatoma cells to hepatocyte-like cells by defined hepatocyte nuclear factors.
    Cheng Z; He Z; Cai Y; Zhang C; Fu G; Li H; Sun W; Liu C; Cui X; Ning B; Xiang D; Zhou T; Li X; Xie W; Wang H; Ding J
    Cell Res; 2019 Feb; 29(2):124-135. PubMed ID: 30560924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Foxa1 and Foxa2 control the differentiation of goblet and enteroendocrine L- and D-cells in mice.
    Ye DZ; Kaestner KH
    Gastroenterology; 2009 Dec; 137(6):2052-62. PubMed ID: 19737569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner.
    Ferri AL; Lin W; Mavromatakis YE; Wang JC; Sasaki H; Whitsett JA; Ang SL
    Development; 2007 Aug; 134(15):2761-9. PubMed ID: 17596284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auto-activation of c-JUN gene by amino acid deprivation of hepatocellular carcinoma cells reveals a novel c-JUN-mediated signaling pathway.
    Fu L; Balasubramanian M; Shan J; Dudenhausen EE; Kilberg MS
    J Biol Chem; 2011 Oct; 286(42):36724-38. PubMed ID: 21862593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deprivation of protein or amino acid induces C/EBPbeta synthesis and binding to amino acid response elements, but its action is not an absolute requirement for enhanced transcription.
    Thiaville MM; Dudenhausen EE; Zhong C; Pan YX; Kilberg MS
    Biochem J; 2008 Mar; 410(3):473-84. PubMed ID: 18052938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Forkhead box protein A2, a pioneer factor for hepatogenesis, is involved in the expression of hepatic phenotype of alpha-fetoprotein-producing adenocarcinoma.
    Yamamura N; Fugo K; Kishimoto T
    Pathol Res Pract; 2017 Sep; 213(9):1082-1088. PubMed ID: 28778497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An endothelial cell niche induces hepatic specification through dual repression of Wnt and Notch signaling.
    Han S; Dziedzic N; Gadue P; Keller GM; Gouon-Evans V
    Stem Cells; 2011 Feb; 29(2):217-28. PubMed ID: 21732480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide location analysis reveals distinct transcriptional circuitry by paralogous regulators Foxa1 and Foxa2.
    Bochkis IM; Schug J; Ye DZ; Kurinna S; Stratton SA; Barton MC; Kaestner KH
    PLoS Genet; 2012; 8(6):e1002770. PubMed ID: 22737085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.